According to the CDC, 38.4 million people -- representing 11.6% of the U.S. -- had diabetes, and another 97.6 million had ...
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...
Three decades of landmark research into type 2 diabetes prevention abruptly ended this month due to government funding cuts.
Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.
Thousands of women claim hair relaxers cause cancer, citing studies linking them to increased risks. Legal battles grow ...
The FDA has extended its review of the ProSense cryoablation system for early-stage breast cancer, with a decision expected ...
9 天
MedPage Today on MSNEndocrine Society's New President-Elect; Judge Stops Compounders; New GLP-1 BenefitsFalling short of expectations, Novo Nordisk said its investigational fixed-dose combination of cagrilintide and semaglutide ...
2 小时
Verywell Health on MSNMounjaro vs. Trulicity: How Do They Compare for Type 2 Diabetes?Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...
The short answer is that the time when babies start teething can be wildly different between different children. While Oller ...
Methylene glycol has been found to be toxicologically equivalent to formaldehyde, also used in hair-straightening treatments ...
Thousands of Black women across the country are suing chemical relaxer manufacturers, alleging the products caused cancer.
A Consumer Reports investigation has found that some infant formulas contain potentially harmful levels of lead and arsenic.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果